Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
19.93
-0.63 (-3.06%)
At close: Dec 5, 2025, 4:00 PM EST
20.32
+0.39 (1.96%)
After-hours: Dec 5, 2025, 4:15 PM EST
Forte Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Cash & Equivalents | 93.41 | 22.24 | 37.13 | 41.1 | 42.04 | 58.77 | Upgrade
|
| Short-Term Investments | - | 36.12 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 93.41 | 58.37 | 37.13 | 41.1 | 42.04 | 58.77 | Upgrade
|
| Cash Growth | 470.89% | 57.21% | -9.67% | -2.25% | -28.45% | 746.88% | Upgrade
|
| Prepaid Expenses | 1 | 2.65 | 1.04 | 0.34 | 0.39 | 0.96 | Upgrade
|
| Other Current Assets | 0.47 | 0.34 | 0.17 | 0.07 | 0.09 | 0.18 | Upgrade
|
| Total Current Assets | 95.41 | 61.35 | 38.33 | 41.51 | 42.52 | 59.9 | Upgrade
|
| Property, Plant & Equipment | 0.15 | 0.08 | 0.11 | - | - | 0.1 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 0.11 | 0.29 | Upgrade
|
| Other Long-Term Assets | 1.53 | 0.14 | 0.54 | 0.49 | 0.68 | 0.96 | Upgrade
|
| Total Assets | 97.09 | 61.56 | 38.98 | 42 | 43.31 | 61.24 | Upgrade
|
| Accounts Payable | 5.49 | 4.88 | 1.42 | 1.15 | 0.95 | 1.24 | Upgrade
|
| Accrued Expenses | 7.5 | 4.2 | 2.24 | 2.03 | 0.81 | 1.02 | Upgrade
|
| Total Current Liabilities | 12.99 | 9.08 | 3.67 | 3.18 | 1.76 | 2.26 | Upgrade
|
| Total Liabilities | 12.99 | 9.08 | 3.67 | 3.18 | 1.76 | 2.26 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 282.68 | 206.46 | 153.83 | 125.84 | 114.7 | 110.42 | Upgrade
|
| Retained Earnings | -198.59 | -154 | -118.52 | -87.04 | -73.17 | -51.46 | Upgrade
|
| Comprehensive Income & Other | -0.01 | 0.01 | 0 | - | - | - | Upgrade
|
| Total Common Equity | 84.1 | 52.48 | 35.31 | 38.82 | 41.55 | 58.98 | Upgrade
|
| Shareholders' Equity | 84.1 | 52.48 | 35.31 | 38.82 | 41.55 | 58.98 | Upgrade
|
| Total Liabilities & Equity | 97.09 | 61.56 | 38.98 | 42 | 43.31 | 61.24 | Upgrade
|
| Net Cash (Debt) | 93.41 | 58.37 | 37.13 | 41.1 | 42.04 | 58.77 | Upgrade
|
| Net Cash Growth | 470.89% | 57.21% | -9.67% | -2.25% | -28.45% | 746.88% | Upgrade
|
| Net Cash Per Share | 7.93 | 20.02 | 29.40 | 59.11 | 75.25 | 199.64 | Upgrade
|
| Filing Date Shares Outstanding | 12.53 | 6.58 | 1.46 | 0.84 | 0.59 | 0.54 | Upgrade
|
| Total Common Shares Outstanding | 17.83 | 6.39 | 1.45 | 0.84 | 0.59 | 0.51 | Upgrade
|
| Working Capital | 82.42 | 52.27 | 34.66 | 38.33 | 40.76 | 57.64 | Upgrade
|
| Book Value Per Share | 4.72 | 8.21 | 24.30 | 46.21 | 70.40 | 114.92 | Upgrade
|
| Tangible Book Value | 84.1 | 52.48 | 35.31 | 38.82 | 41.55 | 58.98 | Upgrade
|
| Tangible Book Value Per Share | 4.72 | 8.21 | 24.30 | 46.21 | 70.40 | 114.92 | Upgrade
|
| Machinery | 0.24 | 0.13 | 0.12 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.